Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care   The Big Story Senate panel clears ...

Here are the key takeaways from the full Times Magazine story about the F.D.A.: The F.D.A.’s regulators have an enormous ...

Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public ...

Unlike Drs. Adam Cifu and John Mandrola, I do not constantly boast of my "nuance" or claim to be a master of "clinical ...

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.

Prescription opioid abuse and its downstream effects have reached epidemic proportions in the United States. On May 26, the Food and Drug Administration (FDA) moved a step closer to providing help to ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

A new indication for omalizumab is prompting clinicians to adjust their approach to oral food challenges, but experts ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines. Newly released documents show the FDA’s vaccine chief, ...